Notably, no effect was observed upon treatment of HCT116 cells with RO5454948, suggesting that the beneficial effect of RO5454948 in cancer cell lines is due to Dyrk1B inhibition and not to Dyrk1A [59]. The gene discussed is DYRK1A; the disease is cancer.